The Cancer Technology Catalyst is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the Catalyst Team is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients. By harnessing a collaborative Team Science approach, the Catalyst Team works closely with Principal Investigators and their team to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies but also strategically position them for successful clinical integration.

The Centre offers a cutting-edge organoid culture and biobank facility, located at the ICR (Chelsea). This facility is a crucial resource for researchers as it enables the cultivation of human cancer organoids and other three-dimensional cancer models. Contact our team members for more information and how to access this facility. 

The Centre provides a microfabrication and prototyping facility, housed at Imperial (South Kensington and White City campuses) for the rapid production of small devices for pre-clinical in vitro studies. Supported by dedicated technicians, the facility has access to clean room facilities and a range of equipment for the development of bespoke devices. This includes 3D printing, laser cutting, electronics and access to an SU8 system for the mask free production of polydimethylsiloxane (PDMS) multilayer devices at 2-micron resolution. The facility can be used for the production of, for example, microfluidic devices, organs-on-chip, biosensors, electrochemical sensors, microneedles and others.